ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RENX Renalytix Plc

29.00
-1.00 (-3.33%)
22 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Renalytix Plc LSE:RENX London Ordinary Share GB00BYWL4Y04 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -3.33% 29.00 28.00 30.00 30.00 29.00 30.00 4,852 12:08:34
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Services, Nec 3.4M -46.22M -0.4626 -0.63 28.98M
Renalytix Plc is listed in the Services sector of the London Stock Exchange with ticker RENX. The last closing price for Renalytix was 30p. Over the last year, Renalytix shares have traded in a share price range of 10.25p to 145.00p.

Renalytix currently has 99,930,156 shares in issue. The market capitalisation of Renalytix is £28.98 million. Renalytix has a price to earnings ratio (PE ratio) of -0.63.

Renalytix Share Discussion Threads

Showing 2776 to 2797 of 2800 messages
Chat Pages: 112  111  110  109  108  107  106  105  104  103  102  101  Older
DateSubjectAuthorDiscuss
11/4/2024
17:30
The company has not given any thoughts on margins, but I would compare it with Pharma where product cost is typically 20% and sales/general costs another 30% for an established product….
There would be costs anyway in operating the test, so the incremental costs of outsourcing might push the lab cost up by a further 10-20%….should still be profitable…but it does allow scalability which is key to RENX being able to penetrate the addressable market.

1jat
09/4/2024
20:24
OK.I hear what you are saying. How do you think that would translate into profit for RENX if they have to follow that kind of model?
f56
09/4/2024
17:26
F56 - how relevant is the invitae case to RENX?
I expect RENX has the IP/technology and will licence testing to labs….they certainly dont have the infrastructure to set up labs, lab cost will take a chunk of the $950 tariff for the test.

1jat
08/4/2024
19:27
Invitae, the testing company, have just gone bankrupt in the US. They managed a significant turnover before running out of cash.
f56
13/3/2024
16:46
If they cant raise the run rate at Mt sinai...and Mt Sinai increases its holding in the company you wonder whats going on. Maybe both are run by idiots. My guess is it goes private in the next year. Delist and carve up between Mills, the bod and Sinai.
mr roper
13/3/2024
14:28
I am encouraged the founders/champions of RENX have bought into the fund raise…..but they are the funder of last resort at the moment.

The fund raise provides an immediate stay of execution for the company and will allow the sale of business process to proceed without a gun to the directors heads….however they need to recognise that either they will need to sell the business or be prepared to fund the company until it can make itself cash generative.

They must hope the continued adoption in clinical standards will result in substantial demand for tests. That is what gives me hope that they can land a decent offer and sell the company.

1jat
12/3/2024
09:53
Good to see Howard Doran appointed as Business Manager to drive sales all of six months ago doesnt even list RENX as his employer. Fact he's yet another one in his mid 60s picking up a pension salary here probably means he's forgotten where he works. They know how to pick them
faz
12/3/2024
09:38
this company could do a GWP...following same scenario..multi billion takeover soon
iceagefarmer
12/3/2024
08:36
Numpties still buying
beatme1
12/3/2024
07:42
Told you:

mortal1ty: Seen this so many times before.

Compnay on its last legs, and needing capital.

Vague bid spec, followed by formal sales process.

Bid rarely comes. Sometimes if it does come it is at a price well below the current price.

If it doesn't come emergency funding needed and business collapses.

mortal1ty
12/3/2024
07:41
Will it be worth buying at 20p though
markth126
12/3/2024
07:40
I did tell people here when the bid first came out.

Someone replied "someone wants to buy in early this morning".

Should have listened.

mortal1ty
12/3/2024
07:19
Utter disgrace
toffeeman
12/3/2024
07:15
Straight from the shafting of PIs 101 guide.Condolences holders
scepticalinvestor
06/3/2024
11:37
Rat has jumped shi
beatme1
05/3/2024
10:49
The $64m question (gosh that used to be an awful lot of money)….is the price at which a deal can be struck. With 100m shares in issue each £1m is roughly 1p to shareholders.
You would think a large diagnostic company would know how to exploit the product and evaluate its prospects….they can afford not to overpay as this is a forced sale…if it were the UK, I would expect a pre-pack administration (not that there are many debts to write off - as I dare say they will all convert to equity).

The Directors can really only resist if they have a viable plan B (until recently plan A that they have not been able/willing to execute).

I need 125p to break even in my small speculative investment here…..I expect a significant loss, anything less than 50% is looking good now as it was down to a 95% loss at one point.

1jat
05/3/2024
08:03
Looks like another big blue day
genierub
04/3/2024
18:16
sale being instigated by Harwood?
1c3479z
04/3/2024
15:58
There will be no gap up tomorrow
beatme1
04/3/2024
15:58
You want to be out now
beatme1
04/3/2024
15:58
USA will crash after hours
beatme1
04/3/2024
15:58
A few pumpers left on lse watch them run and sell before cloaeb
beatme1
Chat Pages: 112  111  110  109  108  107  106  105  104  103  102  101  Older

Your Recent History

Delayed Upgrade Clock